Long non-coding RNAs (lncRNAs) have been implicated in numerous developmental processes. In a technical and bioinformatics tour-de-force, He et al. (2017) provide critical insight into the dynamics of lncRNA expression, function, and mechanism during oligodendrocyte development and after injury.
One of the primary tenets of molecular biology is the transcription of mRNA from DNA and the subsequent translation of mRNA into protein. Since the inception of the ''central dogma'' over 50 years ago, delineating the mechanisms that oversee both transcription and translation have remained fundamental questions in the field of biology that have far-reaching implications in health and disease. Studies on gene transcription have identified a plethora of regulatory factors that can be broadly grouped into three key categories: (1) basal regulatory factors that associate with RNA polymerase, (2) transcription factors that recognize specific DNA motifs, and (3) epigenetic modification of chromatin, which influences DNA accessibility.
Over the past two decades, it has become appreciated that there are additional regulatory layers associated with gene transcription, including microRNAs and other classes of nonprotein-coding RNA molecules. As with most scientific disciplines, advances in technology are coupled with a deeper, and often unexpected, understanding of the underlying complexities of the associated systems. Indeed, recent advances in next-generation sequencing (NGS) of the human genome revealed that only one-fifth of the total transcription occurs in protein-coding genes, suggesting an abundance of noncoding RNA species in the mammalian transcriptome. Such high-resolution mapping of the transcriptome led to the discovery of long non-coding RNAs (lncRNAs), which have been implicated in the regulation of nearly all aspects of gene transcription, including the basal transcriptional apparatus, microRNA regulation, and epigenetic phenomenon.
Given that lncRNAs comprise a new layer of transcriptional regulation, recent efforts have focused on the identification of tissue and lineage specific cohorts. Moreover, because many developmental processes have clearly defined transcriptional inputs and subsequent cellular outputs, understanding how lncRNAs influence cell-fate decisions has provided a framework for delineating how they interface with these associated transcriptional mechanisms. The developing brain is a particularly rich source of lncRNAs where their expression is dynamically regulated and there is increasing evidence that they directly contribute to the production of diverse cell types during central nervous system (CNS) development (Fatica and Bozzoni, 2014; Perry and Ulitsky, 2016; Ramos et al., 2015) . Recent efforts have focused on utilizing cell-type-or developmental-stage-specific transcriptome data for identifying and functionally characterizing lncRNAs during neural precursor, neuronal, or oligodendrocyte (OL) lineage differentiation. Mercer et al. (2010) utilized custom microarray analysis to define cohorts of lncRNAs that exhibit dynamic expression patterns during the neuronal-glial fate transition and during oligodendrocyte lineage specification. Dong et al. (2015) used RNA sequencing (RNAseq) to characterize the lncRNA transcriptome of neuronal and glial cells in the mouse brain. Furthermore, they identified an lncRNA, lnc-OPC, which is specifically expressed in oligodendrocyte precursor cells (OPC), and found that it contributes to the early specification of OPCs from neural stem cells. These studies and others highlight the importance of better understanding the biology of lncRNA regulation and function.
In this issue of Neuron, He et al. (2017) catalog the repertoire of lncRNA expression across the various stages of oligodendrocyte differentiation. Oligodendrocytes are the myelinating cells of the CNS and have well-defined stages of lineage development and associated transcriptional mechanisms, making them an ideal CNS lineage in which to identify dynamic lncRNA expression profiles. Paired-ended NGS and de novo transcriptome reconstruction were utilized to profile lncRNAs during oligodendrocyte differentiation and maturation, uncovering more than 500 unannotated lncRNA transcripts (lncOLs) across OL lineage differentiation. Subsequent profiling of epigenetic patterns associated with these lncOLs revealed three previously identified lncRNAs, lncOL1-lncOL3, and three novel lncRNAs, lncOL4-lncOL6. Further analysis determined that their expression is dynamic over the course of OL lineage differentiation. These efforts provided a more comprehensive annotation of lncRNA expression across the course of OL lineage specification and maturation. These restricted expression patterns of lncOLs begs the question: what is the functional role of these lncOLs in the CNS?
While knockout (KO) mouse models provide a powerful means to investigate lncRNA function, to date, very few lncRNA mutant mice have been generated as lncRNA structure, and potential overlap with other transcripts complicate gene manipulation and analysis. Furthermore, several lncRNA knockout mouse lines have yielded modest phenotypes. He et al. (2017) tackled this challenge by combining a battery of in vitro and in vivo gene manipulation approaches to address the function of an OL-restricted lncRNA, lncOL1. Gain-of-function studies both in vitro and in the developing mouse brain indicate that lncOL1 is sufficient for OL differentiation while whole mouse CRISPR-CAS9-mediated knockout of lncOL1 led to defects in OL differentiation and myelination. Strikingly, this same phenomenon was observed in a demyelinating injury model, indicating that lncOL1 also contributes to myelin regeneration and implicating it in myelin-associated neurological disorders. However, under both normal and injury conditions, myelination did eventually recover suggesting that lncOL1 is important for the timing of OL differentiation and myelination. Indeed, this would be consistent with suggested roles for lncRNAs as fine tuners of differentiation or may indicate some functional redundancy with other factors.
Several molecular mechanisms utilized by lncRNAs to regulate transcription and cellular differentiation has been described (Fatica and Bozzoni, 2014) . These mechanisms often employ epigenetic regulation through the PRC2 complex that induces gene silencing via histone methylation and deacetylation (Davidovich and Cech, 2015) . He et al. (2017) go on to demonstrate that Suz12-containing PRC2 complex is required to silence the OPC transcriptional program and promote OL differentiation. Moreover, lncOL1 function is inhibited by loss of Suz12 activity indicating that its ability to influence OL differentiation requires the presence of Suz12-PRC2 complex. These results are consistent with recent reports where PRC2-mediated silencing contributes to the differentiation of OLs (Emery and Lu, 2015) . Profiling of lncOL1-KO OLs revealed a derepression of Suz12 target genes (OPC program), indicating that lncOL1 is critical for the silencing of the Suz12 target genes. In addition, RNA immunoprecipitation demonstrated that lncOL1 and Suz12 form a complex, while LncOL1-KO OLs failed to recruit Suz12 to its target promoters. Put together, a model emerges where lncOL1 promotes OL differentiation by interacting with Suz12 and recruiting Suz12 to its target genes (Figure 1) .
Previous studies have supported a role for lncRNAs in a number of developmental processes. In a technical and bioinformatics tour-de-force, He et al. (2017) provide a more comprehensive view of the dynamics of lncRNA expression and a much deeper mechanistic understanding of how lncOL1 contributes to the timing of myelination. Additional facets of its function are reflected in their observation that lncOL1, while not expressed in adult spinal cord, is re-expressed after demyelinating injury and important for proper timing of remyelination. Given the function of lncOL1 in OL differentiation and myelination, it is interesting to speculate that lncOLs may be harnessed for therapeutic intervention, as the restricted spatio-temporal expression patterns of lncRNAs make them attractive therapeutic targets. Indeed, lncRNAs are currently used as diagnostic and prognostic markers for several cancers (Huarte, 2015) . Mutations in a number of lncRNA loci have also been associated with an array of neurological disorders, including Alzheimer's disease and autism (Hart and Goff, 2016) . It may also be important to understand the lncRNA-protein interactions, as this may provide an additional avenue for therapeutic interventions.
This study and others provide a roadmap for future investigations aimed at harnessing this new transcriptional layer in the context of the labyrinth that is cell lineage development. Clearly, we have just begun to scratch the surface of understanding how lncRNAs influence cellular behaviors and associated diseases. Given that lncRNA expression is often restricted to specific cell lineages or ''states,'' one can imagine that they may also demonstrate dynamic expression and function under different physiological conditions in the adult or in an ''activity''-dependent manner across diverse brain regions. Finally, given that lncRNAs comprise approximately 80% of the transcriptome, advances in NGS and bioinformatics may conjure up additional roles for this class of RNA outside of the realm of transcriptional regulation. In cells lacking lncOL1, the OPC program is active, which inhibits oligodendrocyte (OL) differentiation. Upon lncOL1 expression, lncOL1 associates with the repressive Suz12-containing PCR2 complex to silence the OPC gene program. This allows for activation of the OL gene regulatory program, suggesting that lncOL1 functions to control the balance between maintaining an OPC state and OL differentiation.
